Correction
Correction
- Aust Prescr 1997;20:20-1
- 1 January 1997
- DOI: 10.18773/austprescr.1997.012
ISSUE 1 JANUARY
The new heparins (Aust Prescr 1996;19:104-8)
A word processing error was introduced into Table 1 after this article had left the Australian Prescriber office. The intended layout for preferred prophylaxis appears in the correct version of the table below.
Table 1
Level of risk of deep venous thrombosis/pulmonary embolism
| Age | <40 | >=40 | >=40 | >=40 |
| Surgery | Minor (≤30 minute) | Major (>30 minute) | Major (>30 minute) |
|
| Additional risk factors | Nil | Nil | Coronary artery disease |
|
| Level of risk | Low | Moderate | High | Very high |
| Risk rate % deep venous thrombosis | 2 | <20 | <40 | >40 |
| fatal pulmonary embolism | 0.002 | <0.04 | <1.0 | >1.0 |
| Preferred prophylaxis | Early ambulation | Low dose UFH twice daily | Low dose UFH 3 times daily or LMWH | Oral anticoagulant (monitored) or LMWH * _________ Thrombophilic states include inherited disorders such as antithrombin III deficiency and acquired disorders such as anti- phospholipid antibody syndromes UFH ______ unfractionated heparin LMWH ____ low molecular weight heparin |
RELATED ARTICLES
Article
The new heparins
Aust Prescr 1996;19:104-8
RELATED ARTICLES
Article
The new heparins
Aust Prescr 1996;19:104-8
